Tianqiao Zhang

5PUBLICATIONS
2CO-AUTHORS
Respiratory diseasesMolecular targetsMajor global burdens of diseaseInfant and child health
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 29, 2026
Complement C5 inhibitor crovalimab for the treatment of paroxysmal nocturnal hemoglobinuria.

|Jun 10, 2025
Effects of sodium-glucose cotransporter 2 inhibitors on cardiomyopathy: a meta-analysis.

Bo Xu, Tianqiao Zhang, Jiecan Zhou

|Jan 22, 2025
A comprehensive review of the efficacy and safety of ertugliflozin.

Bo Xu, Yilin Liu, Tianqiao Zhang

|Dec 04, 2024
Investigating Sodium-Glucose Cotransporter 2 Inhibitors Versus Other Glucose-Lowering Drugs on Ventricular Arrhythmias or Sudden Cardiac Death Using the US FDA Adverse Event Reporting System.

Bo Xu, Tianqiao Zhang, Bo Kang

|Oct 16, 2024
Type II RAF inhibitor tovorafenib for the treatment of pediatric low-grade glioma.

Tianqiao Zhang, Bo Xu, Fan Tang

Pageof 1

Frequent Collaborators

5 joint publications

Bo Xu

5 joint publications

Jiecan Zhou